374 related articles for article (PubMed ID: 25255244)
1. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.
Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L
PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244
[TBL] [Abstract][Full Text] [Related]
2. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
[TBL] [Abstract][Full Text] [Related]
4. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
Boccone L; Dessì V; Meloni A; Loudianos G
Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular unit disruption and blood-brain barrier leakage in MCT8 deficiency.
Guillén-Yunta M; Valcárcel-Hernández V; García-Aldea Á; Soria G; García-Verdugo JM; Montero-Pedrazuela A; Guadaño-Ferraz A
Fluids Barriers CNS; 2023 Nov; 20(1):79. PubMed ID: 37924081
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish as a model for monocarboxyl transporter 8-deficiency.
Vatine GD; Zada D; Lerer-Goldshtein T; Tovin A; Malkinson G; Yaniv K; Appelbaum L
J Biol Chem; 2013 Jan; 288(1):169-80. PubMed ID: 23161551
[TBL] [Abstract][Full Text] [Related]
7. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
[No Abstract] [Full Text] [Related]
8. Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish.
Zada D; Tovin A; Lerer-Goldshtein T; Appelbaum L
Dis Model Mech; 2016 Nov; 9(11):1339-1348. PubMed ID: 27664134
[TBL] [Abstract][Full Text] [Related]
9. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development.
Vancamp P; Darras VM
Gen Comp Endocrinol; 2018 Sep; 265():219-229. PubMed ID: 29183795
[TBL] [Abstract][Full Text] [Related]
10. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
Vancamp P; Demeneix BA; Remaud S
Front Endocrinol (Lausanne); 2020; 11():283. PubMed ID: 32477268
[TBL] [Abstract][Full Text] [Related]
11. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
[TBL] [Abstract][Full Text] [Related]
12. Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target.
Shaji D
Curr Drug Discov Technol; 2021; 18(1):105-112. PubMed ID: 31774046
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
[TBL] [Abstract][Full Text] [Related]
14. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish - An emerging model to explore thyroid hormone transporters and psychomotor retardation.
Zada D; Blitz E; Appelbaum L
Mol Cell Endocrinol; 2017 Dec; 459():53-58. PubMed ID: 28274736
[TBL] [Abstract][Full Text] [Related]
16. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
[TBL] [Abstract][Full Text] [Related]
17. Disorder of thyroid hormone transport into the tissues.
Groeneweg S; Visser WE; Visser TJ
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
[TBL] [Abstract][Full Text] [Related]
18. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
Armour CM; Kersseboom S; Yoon G; Visser TJ
PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
[TBL] [Abstract][Full Text] [Related]
19. TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice.
Reinwald JR; Weber-Fahr W; Cosa-Linan A; Becker R; Sack M; Falfan-Melgoza C; Gass N; Braun U; Clemm von Hohenberg C; Chen J; Mayerl S; Muente TF; Heuer H; Sartorius A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555189
[TBL] [Abstract][Full Text] [Related]
20. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
